BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 23685455)

  • 1. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence.
    Kaplon J; Zheng L; Meissl K; Chaneton B; Selivanov VA; Mackay G; van der Burg SH; Verdegaal EM; Cascante M; Shlomi T; Gottlieb E; Peeper DS
    Nature; 2013 Jun; 498(7452):109-12. PubMed ID: 23685455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells.
    Cesi G; Walbrecq G; Zimmer A; Kreis S; Haan C
    Mol Cancer; 2017 Jun; 16(1):102. PubMed ID: 28595656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis.
    Li X; Jiang Y; Meisenhelder J; Yang W; Hawke DH; Zheng Y; Xia Y; Aldape K; He J; Hunter T; Wang L; Lu Z
    Mol Cell; 2016 Mar; 61(5):705-719. PubMed ID: 26942675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Connection of Inflammatory Pain: Pivotal Role of a Pyruvate Dehydrogenase Kinase-Pyruvate Dehydrogenase-Lactic Acid Axis.
    Jha MK; Song GJ; Lee MG; Jeoung NH; Go Y; Harris RA; Park DH; Kook H; Lee IK; Suk K
    J Neurosci; 2015 Oct; 35(42):14353-69. PubMed ID: 26490872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.
    Vredeveld LC; Possik PA; Smit MA; Meissl K; Michaloglou C; Horlings HM; Ajouaou A; Kortman PC; Dankort D; McMahon M; Mooi WJ; Peeper DS
    Genes Dev; 2012 May; 26(10):1055-69. PubMed ID: 22549727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyruvate as a pivot point for oncogene-induced senescence.
    Olenchock BA; Vander Heiden MG
    Cell; 2013 Jun; 153(7):1429-30. PubMed ID: 23791173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic
    Cenigaonandia-Campillo A; Serna-Blasco R; Gómez-Ocabo L; Solanes-Casado S; Baños-Herraiz N; Puerto-Nevado LD; Cañas JA; Aceñero MJ; García-Foncillas J; Aguilera Ó
    Theranostics; 2021; 11(8):3595-3606. PubMed ID: 33664850
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma.
    Scortegagna M; Ruller C; Feng Y; Lazova R; Kluger H; Li JL; De SK; Rickert R; Pellecchia M; Bosenberg M; Ronai ZA
    Oncogene; 2014 Aug; 33(34):4330-9. PubMed ID: 24037523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-inflammatory Macrophages Sustain Pyruvate Oxidation through Pyruvate Dehydrogenase for the Synthesis of Itaconate and to Enable Cytokine Expression.
    Meiser J; Krämer L; Sapcariu SC; Battello N; Ghelfi J; D'Herouel AF; Skupin A; Hiller K
    J Biol Chem; 2016 Feb; 291(8):3932-46. PubMed ID: 26679997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the (V600E)BRAF oncogene.
    Hall A; Meyle KD; Lange MK; Klima M; Sanderhoff M; Dahl C; Abildgaard C; Thorup K; Moghimi SM; Jensen PB; Bartek J; Guldberg P; Christensen C
    Oncotarget; 2013 Apr; 4(4):584-99. PubMed ID: 23603840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic activation of pyruvate dehydrogenase alters oxidative substrate selection to induce skeletal muscle insulin resistance.
    Rahimi Y; Camporez JP; Petersen MC; Pesta D; Perry RJ; Jurczak MJ; Cline GW; Shulman GI
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16508-13. PubMed ID: 25368185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible phosphorylation of pyruvate dehydrogenase in rat skeletal-muscle mitochondria. Effects of starvation and diabetes.
    Fuller SJ; Randle PJ
    Biochem J; 1984 Apr; 219(2):635-46. PubMed ID: 6331393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin Therapy Results in Mitigation of ATP Loss after Irradiation Combined with Wound Trauma: Preservation of Pyruvate Dehydrogenase and Inhibition of Pyruvate Dehydrogenase Kinase 1.
    Swift JM; Smith JT; Kiang JG
    Radiat Res; 2015 Jun; 183(6):684-92. PubMed ID: 26010714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras-mediated modulation of pyruvate dehydrogenase activity regulates mitochondrial reserve capacity and contributes to glioblastoma tumorigenesis.
    Prabhu A; Sarcar B; Miller CR; Kim SH; Nakano I; Forsyth P; Chinnaiyan P
    Neuro Oncol; 2015 Sep; 17(9):1220-30. PubMed ID: 25712957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiolipin-induced activation of pyruvate dehydrogenase links mitochondrial lipid biosynthesis to TCA cycle function.
    Li Y; Lou W; Raja V; Denis S; Yu W; Schmidtke MW; Reynolds CA; Schlame M; Houtkooper RH; Greenberg ML
    J Biol Chem; 2019 Jul; 294(30):11568-11578. PubMed ID: 31186346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenyl butyrate inhibits pyruvate dehydrogenase kinase 1 and contributes to its anti-cancer effect.
    Zhang W; Zhang SL; Hu X; Tam KY
    Eur J Pharm Sci; 2017 Dec; 110():93-100. PubMed ID: 28450154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and oncogenic adaptations to pyruvate dehydrogenase inactivation in fibroblasts.
    Wang H; Lu J; Kulkarni S; Zhang W; Gorka JE; Mandel JA; Goetzman ES; Prochownik EV
    J Biol Chem; 2019 Apr; 294(14):5466-5486. PubMed ID: 30755479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth suppression by dual BRAF(V600E) and NRAS(Q61) oncogene expression is mediated by SPRY4 in melanoma.
    Kumar R; Njauw CN; Reddy BY; Ji Z; Rajadurai A; Klebanov N; Tsao H
    Oncogene; 2019 May; 38(18):3504-3520. PubMed ID: 30651601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near-genomewide RNAi screening for regulators of BRAF(V600E) -induced senescence identifies RASEF, a gene epigenetically silenced in melanoma.
    Kaplon J; Hömig-Hölzel C; Gao L; Meissl K; Verdegaal EM; van der Burg SH; van Doorn R; Peeper DS
    Pigment Cell Melanoma Res; 2014 Jul; 27(4):640-52. PubMed ID: 24703243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy.
    Anwar S; Shamsi A; Mohammad T; Islam A; Hassan MI
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188568. PubMed ID: 34023419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.